Introduction {#s1}
============

The auditory epithelium is a delicate structure located in the cochlea that is composed of sensory hair cells (HCs) and nonsensory support cells (SCs). During early development of mouse cochlea, the transcription factor sox2 is required to determine the prosensory region that mainly contains progenitors ([@bib23]; [@bib24]; [@bib13]). From E12.5 to E14.5 sox2^+^ progenitors exit cell cycle and differentiate into auditory HCs and SCs. Basic helix-loop-helix (bHLH) transcription factor atoh1 acts as the cardinal gene initiating auditory HC differentiation since atoh1 deficiency causes complete loss of cochlear HCs ([@bib5]). A subset of post-mitotic progenitors start to express high levels of atoh1 and downregulate sox2 expression to differentiate into the HC precursors ([@bib13]; [@bib61]; [@bib7]; [@bib58]). Afterwards, their terminal differentiation toward mature HCs is promoted by the upregulation of atoh1 target genes, such as pou4f3 ([@bib6]). In the meanwhile, differentiating HCs secret Notch ligands to activate Notch pathway, which inhibits atoh1 expression in neighboring cells and forces them to adopt the SC fate ([@bib1]; [@bib10]; [@bib26]).

The zebrafish lateral line is a mechanosensory organ composed of a series of neuromasts distributed on the body surface for detecting water flow. The lateral line HCs share similarities with their counterparts in mammalian inner ear in morphology, function and developmental pathways ([@bib49]; [@bib35]). Each neuromast contains sensory HCs in the center surrounded by SCs and mantle cells (MCs). Aminoglycoside antibiotics, such as neomycin, ablates mature HCs and initiates robust mitotic regeneration that is characterized with SC division and differentiation ([@bib18]; [@bib22]; [@bib51]; [@bib29]; [@bib39]). The powerful capacity to regenerate HCs sustains after multiple rounds of damage, and retains throughout lifetime ([@bib12]; [@bib37]). Even after severe loss of the tissue integrity, the residual SCs have high potential to recover the neuromast by acting plastic to generate all three cell types ([@bib46]). Like in inner ear, *atoh1a* is expressed in HC precursors but not mature HCs in neuromast while *sox2* is expressed in a part of SCs and MCs ([@bib29]; [@bib28]). Sox2^+^ SCs behave as progenitors to proliferate and differentiate through activation of canonical Wnt pathway during regeneration ([@bib19]; [@bib21]). However, it is unknown how regeneration is initiated when sox2^+^ progenitors are absent.

Mammalian sensory HCs are vulnerable to damages caused by antibiotics, chemotherapeutical drugs and noise, which results in various hearing and balance diseases ([@bib11]). Until now, the principal method used to initiate auditory HC regeneration in mammalian inner ear is to induce the transdifferentiation of SCs into HCs by upregulating atoh1 expression. For example, many studies tried to overexpress atoh1 in SCs with adenovirus, or used Notch inhibitor to increase atoh1 expression ([@bib4]; [@bib32]; [@bib20]; [@bib54]). However, because the efficiency of HC induction is very low and SCs are lost due to transdifferentiation, very limited progress toward hearing recovery has been achieved ([@bib11]; [@bib60]; [@bib9]). New strategies of restoring sox2^+^ progenitors to initiate mitotic regeneration would be more promising to realize functional regeneration in mammalian adult inner ear. Unfortunately, very little is known whether and how sox2^+^ progenitors can be restored in sensory epithelium.

Here in the zebrafish lateral line, we found that exhausted sox2^+^ progenitors were able to restore quickly for initiating HC regeneration in severe injury. *Atoh1a*^+^ HC precursors were the main population that survived post severe injury and dedifferentiated into s*ox2*^+^ progenitors through yap-lin28a pathway.

Results {#s2}
=======

Exhausted sox2^+^ progenitors were quickly recovered by intensive proliferation post severe injury {#s2-1}
--------------------------------------------------------------------------------------------------

It is well documented that Notch signaling pathway negatively regulates the differentiation of SCs into HCs ([@bib29]; [@bib17]). Using the γ-secretase inhibitor LY411575 to inhibit Notch pathway from 3-day-post-fertilization (dpf) to 5dpf, we found that SCs were exhausted by persistent differentiation into HCs ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Neomycin was used to ablate mature HCs following LY treatment (LY+neo), which leads to the severe injury with both HCs and SCs being ablated. Sox2 marks the proliferative progenitors that produce both SCs and HCs in homeostatic and regenerative neuromasts ([@bib19]). We analyzed sox2^+^ cells in neo- and LY+neo-treated neuromast by immunostaining with anti-sox2 antibody. While the distribution of sox2^+^ cells moved to the center post neo compared with normal larvae, the number was not changed. But sox2^+^ cell number was dramatically decreased after LY or LY+neo ([Figure 1A--B](#fig1){ref-type="fig"}). Surprisingly, sox2^+^ progenitors were able to recover quickly post LY+neo. A few sox2^+^ progenitors appeared early at 6 hr, with increased sox2^+^ progenitors being regenerated afterwards and recovered to normal level by 48 hr. In [Figure 1A](#fig1){ref-type="fig"}, *ET4*^+^ HCs appeared at 48 hr post LY+neo, suggesting that HC regeneration happened after the recovery of sox2^+^ progenitors.

![Exhausted sox2^+^ progenitors were able to restore quickly post severe injury.\
(**A, B**) *ET4;ET20* larvae were treated with neomycin, LY411575 (3dpf-5dpf), or neomycin following LY (LY+neo), and collected at indicated time points post neomycin treatment for sox2 immunostaining. The number of sox2^+^ progenitors was not affected post neo, while it was significantly decreased in LY and LY+neo-0h. The sox2^+^ progenitors were regenerated post LY+neo and recovered to normal level at 48 hr post LY+neo. (**C, D**) The *sox2:GFP* reporter was treated with LY from 3dpf to 5dpf to exhaust GFP+ progenitors. GFP+ progenitors cannot be regenerated when resting in normal medium for 2 days post LY treatment (LY+rest). In contrast, sox2^+^ progenitors were quickly recovered to normal level at 2-day post LY+neo. Scale bar equals 10 μm. All groups are compared with 5dpf unless indicated.](elife-55771-fig1){#fig1}

In addition to sox2 antibody staining, we also used *sox2-2a-GFP* knock-in reporter (*sox2:GFP*) ([@bib40]) to observe the recovery of sox2^+^ progenitors. GFP-positive cells in neuromast, which were mostly co-labeled by sox2 antibody, were significantly decreased in LY, and recovered to normal level at 48 hr post LY+neo. In contrast, the exhausted sox2^+^ progenitors were not recovered without severe injury ([Figure 1C--D](#fig1){ref-type="fig"}). These results indicate that sox2^+^ progenitors in the zebrafish lateral line have high potential to regenerate themselves when exhausted by severe injury.

During regeneration, three types of cell divisions can be detected by combining EdU staining with GFP expression in *ET4;ET20* ([@bib39]). First, EdU is incorporated in differentiating cells when one HC precursor divides into two HCs (*ET4*^+^EdU^+^, or HC^+^). The second type is SC proliferation in which one SC divides into two SCs (ET4^-^ET20^-^EdU^+^, or SC^+^). The third type is mantle cell (MC) proliferation in which one MC divides into two MCs (*ET20*^+^EdU^+^, or MC^+^). Our results showed that proliferation in SCs or MCs post severe injury is highly increased compared with neo-induced normal injury, while HC differentiation is decreased ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). By time lapse, we recorded 12 times of MC or SC divisions in one neuromast from 24 hr to 40 hr post LY+neo, but none of them was differentiation ([Video 1](#video1){ref-type="video"}). These results indicate that intensive proliferation is necessary to accomplish regeneration post severe injury.

###### *ET4;ET20;cldnB:H2Amcherry* larvae treated with LY+neo were processed for time lapse.

Results showed the intensive cell divisions (CDs) during severe-injury-induced regeneration. Scale bar equals 10 μm.

Activated yap upregulated *lin28a* expression in *atoh1a*^+^ HC precursors upon severe injury {#s2-2}
---------------------------------------------------------------------------------------------

We next investigated the mechanism involved in progenitor recovery. Previously, we have collected samples of regenerating neuromasts for RNA-Seq analysis ([@bib22]) and identified that *lin28a* was transiently upregulated post neomycin treatment ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). By in situ hybridization, we verified that *lin28a* was not expressed in the developing lateral line primordium or neuromast ([Figure 2A](#fig2){ref-type="fig"}). Neomycin treatment and other types of HC injuries, including heavy metal (copper sulfate) or chemotherapeutic drug (cisplatin), induced sporadic *lin28a* expression ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). Interestingly, LY+neo induced much higher expression of *lin28a* compared with neo alone ([Figure 2B](#fig2){ref-type="fig"}). Since LY+neo induced more cell death than neo as illustrated by ablation of *s100t* expressing HCs, we tested whether *lin28a* induction is proportional to the injury size. We used laser ablation to manipulate the number of injured cells in LY-treated neuromast. Low level of *lin28a* was induced when five HCs were ablated while higher level of *lin28a* was observed when sixteen HCs were ablated. Furthermore, we found that the ablation of SCs could also induce *lin28a* expression ([Figure 2---figure supplement 1C--D](#fig2s1){ref-type="fig"}).

![Activated y*ap* upregulate *lin28a* transcription in *atoh1a*^+^ HC precursors post severe injury.\
(**A**) *Lin28a* was not expressed in the developing lateral line primordium or neuromast. (**B**) Treatment with Notch inhibitor LY411575 from 3dpf to 5dpf increased expression *atoh1a* and *s100t*. More *lin28a* expression was observed in LY+neo-1h compared with neo-1h. No *lin28a* was detected at 5 hr post LY+neo or neo. (**C**) The number of *atoh1a*-transcribed cells detected by in situ were higher at 1 hr post LY+neo compared with LY. (**D**) Double fluorescent in situ showed that *lin28a* was co-expressed with *atoh1a* post neo or LY+neo. (**E**) Induction of *lin28a* post injury was increased when *atoh1a* was overexpressed in *hs:atoh1a*. (**F**) *Lin28a* expression was completely blocked when *atoh1a* was inhibited in *hs:notch1a*. (**G**) Western blot results showed that LY+neo induced higher *yap* expression compared with neo alone. (**H**) Motifs of *yap* and *tead1* (co-transcriptional factor of *yap*) binding sites were predicted near *lin28a* transcriptional start site. CHIP-PCR results verified that *yap* directly binds the predicted motif. (**I and J**) Inhibition of *yap* using verteporfin or *yap* mutant blocked *lin28a* induction post LY+neo. Scale bar equals 10 μm.](elife-55771-fig2){#fig2}

*Atoh1a* is a master gene for HC specification and labels mostly HC precursors including differentiating HCs and young HCs ([@bib7]; [@bib28]). We noticed that *atoh1a*^+^HC precursors were the main population that survived post LY+neo ([Figure 2C](#fig2){ref-type="fig"}). Using double fluorescent in situ, it was verified that *lin28a* was induced in *atoh1a*^+^ HC precursors in both neo- and LY+neo-treated neuromasts ([Figure 2D](#fig2){ref-type="fig"}). We further assessed the effect of *atoh1a* expression on *lin28a* induction. We used *hs:atoh1a* to induce *atoh1a* expression after heat shock and found that neo-induced *lin28a* was increased ([Figure 2E](#fig2){ref-type="fig"}). In contrast, *lin28a* induction post LY+neo was completely blocked when *atoh1a* expression was inhibited in *hs:notch1a* ([Figure 2F](#fig2){ref-type="fig"}). All these results indicate that *lin28a* was induced in *atoh1a*^+^ HC precursors post injury.

We further analyzed the upstream pathway that induce lin28a post injury. It's documented that Wnt activation regulates *lin28a* expression ([@bib55]), so we first examined whether Wnt activation acts upstream to induce *lin28a* expression post injury. We used *hs:dkk1* to inhibit Wnt activation and found that *lin28a* induction post injury was not affected ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). Because Hippo pathway critically regulates regeneration of many tissues ([@bib15]; [@bib16]; [@bib34]), we therefore tested the expression of *yap* and *taz*, two cardinal mediators of Hippo pathway. We found the protein levels of yap was up-regulated at 1 hr post LY+neo while taz was increased until 5 hr ([Figure 2G](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). By immunostaining, more yap was also dectected in LY+neo-treated neuromast cells compared with neo. Yap expression was inhibited when *atoh1a* is inhibited with *hs:notch1a*, which suggests that yap is activated in *atoh1a*^+^ HC precursors ([Figure 2---figure supplement 2D--G](#fig2s2){ref-type="fig"}). Expressions of the classic yap target genes, such as cyr61 and ctgfa, and the Hippo pathway genes, such as yap and mst2, were dramatically increased post LY+neo ([Figure 2---figure supplement 2H--I](#fig2s2){ref-type="fig"}), which was blocked with verteporfin (an inhibitor of yap-mediated transcription by blocking yap-tead1 interaction).

Interesting we found a conserved yap binding motif located at 100 bp downstream of lin28a transcription start site, where a tead1 binding motif is located nearby. We used CHIP-PCR to verify that yap directly binds to this region of *lin28a* promoter post severe injury ([Figure 2H](#fig2){ref-type="fig"}). In addition, LY+neo-induced *lin28a* expression was blocked in verteporfin or in yap mutant ([Figure 2I--J](#fig2){ref-type="fig"}). Taken together, we found that *yap* is highly activated by severe injury and directly binds *lin28a* promoter to initiate its transcription in *atoh1a*^+^ HC precursors.

Yap-lin28a pathway is necessary and sufficient to promote progenitor recovery {#s2-3}
-----------------------------------------------------------------------------

To determine whether *lin28a* is required for HC regeneration, we generated a *lin28a* mutant allele (*lin28a\^psi37*, referred to as *lin28a-*) that harbors a deletion of five nucleotides and causes a premature stop codon within the cold shock domain ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We found that *lin28a* deficiency had no effect on HC or SC number in homeostasis, nor did it affect exhaustion of sox2^+^ progenitors post LY or LY+neo ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Since LY+neo treatment substantially enhanced *lin28a* expression, we examined whether *lin28a* deficiency affected LY+neo-induced regeneration. We found that the regenerated HC number was decreased by *lin28a* deficiency ([Figure 3A](#fig3){ref-type="fig"}). In addition, the number of regenerated SCs ([Figure 3A](#fig3){ref-type="fig"}) and the proliferative SCs ([Figure 3B](#fig3){ref-type="fig"}) were both significantly decreased. The EdU-positive SC cells that were located in each quadrant with no polarization in sibling post LY+neo were almost cleared in *lin28a* mutant ([Figure 3C--D](#fig3){ref-type="fig"}). In contrast, the EdU-positive SC number post neo is not affected by *lin28a* deficiency ([Figure 3E](#fig3){ref-type="fig"}), indicating that *lin28a* is not required for neo-induced regeneration.

![Yap-lin28a pathway is essentially required for progenitor recovery post severe injury.\
(**A**) The number of SCs and total cells were counted at 48 hr post LY+neo and were significantly decreased in *lin28a* mutant compared with sibling. (**B--E**) The *ET4;ET20* larvae were incorporated with EdU post neo or LY+neo treatment. Three populations labeled with *ET4*^+^EdU^+^ (HC^+^), *ET20*^+^EdU^+^ (MC^+^) or ET4^-^ET20^-^EdU^+^ (SC^+^) were counted and recorded with location information. The proliferative SCs post LY+neo were significantly decreased in *lin28a* mutant compared with sibling (**B and C**), while not changed in neo-induced regeneration (**E**). (**D**) EdU plots show the positions of EdU^+^ nuclei of 18 neuromasts superimposed on the same plane, and rose diagrams document the angular positions of SC^+^. The results show that the proliferative SCs are evenly distributed in each quadrant with no polarization post LY+neo. (**F**) LY+neo-induced Edu incorporation was significantly reduced in yap mutant. (**G**) The *hs:lin28a* larvae were heat-shocked and pre-treated with 10 μM verteporfin before adding neomycin. Samples were collected at 14 hr post LY+neo for EdU^+^ cell counting. Proliferation (SC^+^) is significantly decreased post LY+neo in verteporfin, which could be rescued by overexpression of *lin28a* with *hs:lin28a*. (**H, I**) The numbers of regenerated sox2+ progenitors (sox2) and proliferative progenitors (sox2EdU) post LY+neo were both reced in *lin28a* mutant. Scale bar equals 10 μm.](elife-55771-fig3){#fig3}

We also observed that yap deficiency induced similar phenotype with *lin28a* mutant. Yap mutation or inhibition with verteporfin caused proliferative deficiency post LY+neo, but has no effect on SC proliferation post neo ([Figure 3F--G](#fig3){ref-type="fig"} and data not shown). We have generated a transgenic line in which heat shock promoter is used to drive *lin28a* expression. Proliferative deficiency in verterporfin was rescued by *hs:lin28a* ([Figure 3G](#fig3){ref-type="fig"}), indicating that *lin28a* acts downstream of yap to promote SC proliferation. We next examined whether *lin28a* is required for recovery of sox2^+^ progenitors post LY+neo. The number of proliferative and regenerated progenitors at 12 hr post injury were significantly reduced in *lin28a* mutant ([Figure 3H--I](#fig3){ref-type="fig"}).

We found that the HC number was not changed in *hs:lin28a,* indicating that *lin28a* has no effect on HC development ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). We next examined whether *lin28a* overexpression is sufficient to promote progenitor proliferation. The number of proliferative SCs was significantly increased when *lin28a* is overexpressed in both homeostatic and neo-treated neuromast, whereas HC differentiation was not changed ([Figure 4A--B](#fig4){ref-type="fig"}). The proliferative SCs are localized in dorsal and ventral poles of neuromast in homeostasis and neo-induced regeneration ([@bib29]; [@bib39]; [@bib50]). The location of proliferative SCs still remain polarized in *hs:lin28a* ([Figure 4C--D](#fig4){ref-type="fig"}). We further examined whether *lin28a* overexpression is sufficient to induce sox2^+^ progenitors, and observed higher number of proliferative progenitors in *hs:lin28a* post LY ([Figure 4E--F](#fig4){ref-type="fig"}).

![Overexpression of *lin28a* is sufficient to restore the exhausted progenitors.\
(**A--D**) *ET4;ET20;hs:lin28a* larvae were incorporated with BrdU for 24 hr following heat-shock and/or neomycin treatment. (**A, B**) Overexpression of *lin28a* increased number of proliferative SCs (SC^+^) in both untreated and neomycin conditions. (**C, D**) BrdU plots and rose diagrams indicate that locations of SC^+^ still remain dorsally and ventrally polarized in *hs:lin28a*. (**E, F**) OverexpressUion of *lin28a* is sufficient to partially restore the exhausted sox2^+^ progenitors post LY. Scale bar equals 10 μm.](elife-55771-fig4){#fig4}

*Atoh1a*^+^ HC precursors gained sox2 expression through Yap-lin28a pathway {#s2-4}
---------------------------------------------------------------------------

Our data indicate that *lin28a* is induced in *atoh1a*^+^ HC precursors post injury, but *lin28a* functions to recover sox2^+^ progenitors during regeneration. To address this paradox, we hypothesized that HC precursors gained sox2 expression to initiate regeneration post severe injury. We co-labeled the expressions of *atoh1a* mRNA and sox2 protein and found that the number of *atoh1a*^+^sox2^+^ cells in LY+neo was significantly increased compared with neo ([Figure 5A--B](#fig5){ref-type="fig"}). In addition, we used *atoh1a:TdTomato* reporter to test whether *atoh1a*^+^ cells expressed sox2 post severe injury. The *atoh1a:TdTomato* reporter labeled partially *ET4*-positive HCs (Figue 5C, ctrl) and also a few cells that are *ET4* negative and sox2 negative which are likely HC precursors ([Figure 5C](#fig5){ref-type="fig"}, yellow arrows in LY). Very few Tomato^+^ cells express sox2 in normal or LY-treated larvae. However, significantly more Tomato^+^ cells turned on sox2 expression at 12 hr and 48 hr post LY+neo and become Tomato^+^sox2^+^ cells ([Figure 5D](#fig5){ref-type="fig"}). We further used time-lapse microscopy to trace *atoh1a:TdTomato* cells and found that the Tomato^+^ cells became HCs in both neo and LY+neo (blue dots in [Figure 5---figure supplement 1A--B](#fig5s1){ref-type="fig"}, [Video 2](#video2){ref-type="video"} and S3). However, it's only in LY+neo-induced severe injury that Tomato^+^ cells became sox2-positive cells labeled by *sox2:GFP* (white dots in [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"} and [Video 3](#video3){ref-type="video"}). We traced the Tomato^+^ cells for their fate becoming HCs, SCs or MCs ([Figure 5---figure supplement 1C--D](#fig5s1){ref-type="fig"}), and the results showed that significantly higher ratio of SCs were labeled by Tomato post LY+neo. More importantly many Tomato^+^ MCs were labeled post LY+neo, but none was detected in normal or neo-treated larvae, suggesting that *atoh1a*^+^sox2^+^ cells gained more potential to produce MCs.

![Yap-lin28a pathway promotes sox2 expression in a*toh1a*^+^ HC precursors.\
(**A--B**) Larvae were stained with sox2 antibody and *atoh1a* RNA probe at 6 hr post neo or LY+neo treatment. The number of *atoh1a*^+^sox2^+^ cells was significantly increased in LY+neo group. (**C--D**) The *atoh1a:TdTomato* larvae were used to trace *atoh1a*^+^ HC precursors in ctrl, LY or LY+neo. Results showed that Tomato^+^ cells labeled partial *ET4*^+^ HCs and *ET4*^-^sox2^-^ HC precursors (yellow arrows). However, many *atoh1a*^+^ cells start to express sox2 from 12 hr post LY+neo and their numbers were significantly increased compared with normal larvae. The arrowheads in (**C**) pointed the *atoh1a*^+^sox2^+^ cells at 48 hr post LY+neo. (**E**) The *atoh1a:TdTomato;hs:lin28a* larvae was treated with LY+neo and verteporfin and collected for immunostaining with sox2 antibody. The cell number of *Tomato*^+^sox2^+^ is decreased in verteporfin and overexpression of *lin28a* could rescue the phenotype. (**F--G**) The LY-treated *hs:lin28a* larvae were heat-shocked to overexpress *lin28a*. Samples were collected for staining with sox2 antibody and *atoh1a* RNA probe. The number of *atoh1a*^+^sox2^+^ cells was significantly increased in *hs:lin28a* group, indicating that *lin28a* is sufficient to express sox2 in *atoh1a*^+^ HC precursors. Scale bar equals 10 μm.](elife-55771-fig5){#fig5}

###### The neuromast of *atoh1a:TdTomato;brn3c:GFP* larvae treated with neo was imaged for time lapse.

Result showed that one Tomato^+^ cell divided and turned into two GFP^+^hair cells post neo. Scale bar equals 10 μm.

###### The neuromast of *atoh1a:TdTomato;sox2:GFP* larvae treated with LY+neo was imaged for time lapse.

One Tomato^+^ cell (blue dot) divided and turned into two HCs that are GFP negative in the center. The other two Tomato^+^ cells (white dots) divided and converted into four sox2^+^ progenitors. Scale bar equals 10 μm.

We further tested whether HC precursors gained sox2 expression through Yap-lin28a pathway. The Yap inhibitor verteporfin decreased Tomato^+^sox2^+^ cell number post severe injury, which was rescued by overexpression of *lin28a* ([Figure 5E](#fig5){ref-type="fig"}). Significantly higher number of *atoh1a*^+^sox2^+^ cells were induced in LY-treated *hs:lin28a* ([Figure 5F--G](#fig5){ref-type="fig"}).

MicroRNA *let7* acts downstream of *lin28a* to activate wnt pathway for promoting regeneration {#s2-5}
----------------------------------------------------------------------------------------------

*Lin28a* has been described to regulate progenitor proliferation in developing inner ear by inhibiting *let7* microRNA processing ([@bib14]). To interrogate the function of *let7* microRNA in regenerating lateral line, we have created *hs:let7* transgenic line. Similar with *lin28a* mutant, *hs:let7* showed the defect of SC proliferation post LY+neo ([Figure 6A](#fig6){ref-type="fig"}). We further found that overexpression of *let7* inhibited *hs:lin28a*-induced proliferation ([Figure 6B](#fig6){ref-type="fig"}), indicating that *let7* acts downstream of *lin28a* to promote regeneration.

![MicroRNA *let7* acts downstream of *lin28a* to activate Wnt pathway for promoting progenitor regeneration.\
(**A**) We created *hs:let7* transgenic line and found that it recapitulates the phenotype of *lin28a-/-* by decreasing proliferative SCs post LY+neo. (**B**) The induction of EdU+ proliferative cells was blocked by *hs:let7*, indicating that *let7* microRNA acts downstream of *lin28a* to induce proliferation. (**C**) In situ hybridization results showed that expression of Wnt pathway genes, such as *wnt10a* and *mycn*, were increased in *hs:lin28a.* The activation of Wnt pathway genes in *hs:lin28a* were blocked when *let7* was overexpressed, indicating that *let7* acts downstream of *lin28a* to inhibit Wnt pathway. (**D**) Expressions of Wnt pathway genes, such as *mycn*, *wnt10a* and *ccnd1* (*cyclind1*), were highly induced at 1 hr post LY+neo in sibling, but were not detected in *lin28a-/-*. (**E**) Inhibition of Wnt pathway with *hs:dkk1* decreased *lin28a*-induced EdU^+^ proliferative cells, indicating that Wnt activation acts downstream of *lin28a* to induce regeneration.](elife-55771-fig6){#fig6}

*Lin28a* has no effect on Notch and Fgf pathways as *her4*, a Notch pathway gene, and *fgf3*, a Fgf pathway gene were not changed in *hs:lin28a* ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We then tested whether Wnt pathway acts downstream of lin28a/let7 to promote proliferation. Overexpression of *lin28a* was sufficient to upregulate Wnt pathway genes *wnt10a* and *mycn*, which was inhibited by overexpression of *let7* ([Figure 6C](#fig6){ref-type="fig"}). Activation of Wnt pathway genes at 1 hr post LY+neo were blocked in *lin28a* mutant ([Figure 6D](#fig6){ref-type="fig"}). We further tested the function of Wnt pathway and found that *lin28a*-induced proliferation were inhibited by *hs:dkk1* in which Wnt activation is blocked ([Figure 6E](#fig6){ref-type="fig"}). To summarize, we found that *lin28a* activates Wnt pathway through *let7* for promoting regeneration.

Discussion {#s3}
==========

The zebrafish lateral line provides a valuable model for studying the mechanism underpinning progenitor regeneration {#s3-1}
--------------------------------------------------------------------------------------------------------------------

Progenitors that divide and differentiate to generate HCs in embryonic development are absent in adult mammalian inner ear, which leads to the regeneration failure post injury. In this study, we simulated the situation of progenitor absence in the zebrafish lateral line through persistent conversion of sox2^+^ progenitors into HCs with Notch inhibitor LY411575. By adding neomycin post LY treatment to ablate HCs, we created a severe injury model in which both HCs and progenitors were eliminated. In big contrast to mammalian inner ear, progenitors in the lateral line were able to quickly restore themselves post severe injury, with HCs being regenerated afterwards. This model provides a valuable tool to elucidate the mechanisms underpinning progenitor recovery for initiating HC regeneration.

Here, we found that yap-lin28a-let7-Wnt axis is essential to promote progenitor regeneration. *Lin28a* is not only necessary but also sufficient to induce progenitor recovery. Our findings elucidate the underlying mechanism of progenitor regeneration, and open a novel avenue of restoring progenitors to enhance mammalian HC regeneration.

In contrast to the situation of severe injury, our data showed that *yap* inhibition or *lin28a* deficiency has no effect on progenitor proliferation post neo ([Figure 3E](#fig3){ref-type="fig"} and data not shown). Wnt pathway, which acts downstream of *lin28a*, is required to induce progenitor proliferation. We found that Wnt pathway was highly activated immediately post severe injury, but was not activated at 1 hr post neo. Since the number of sox2^+^ progenitors were not reduced post neo, it seems not necessary to activate Wnt for producing more progenitors. Therefore, our results identified that Yap-lin28a pathway functions specifically in severe-injury induced regeneration for promoting progenitor recovery ([Figure 7](#fig7){ref-type="fig"}).

![Schematic model illustrates how Yap-lin28a pathway regulates progenitor regeneration post severe injury.\
(**A**) It's known that sox2+ progenitors that are preserved post neo-induced HC injury divide and differentiate to regenerate HCs. To simulate the situation in mammalian inner ear where the progenitors are absent, we created a severe injury model by exhausting sox2^+^ progenitors with Notch inhibitor and ablating mature HCs with neomycin. We found that the exhausted sox2^+^ progenitors in severe injury have high potential to restore themselves within 48 hr, with HCs being regenerated afterwards. The *atoh1a^+^* HC precursors, the main population that survived post severe injury, were converted into proliferative progenitors to initiate regeneration through yap-lin28a pathway. (**B**) *Yap* is activated in *atoh1a*^+^ HC precursors post severe injury and binds directly to *lin28a* promoter for initiating its transcription. *Lin28a* activates Wnt pathway through microRNA *let7* to promote regenerative proliferation.](elife-55771-fig7){#fig7}

The upstream signal that activates yap post injury {#s3-2}
--------------------------------------------------

Previous studies have described yap as an important regulator in mediating regeneration ([@bib16]; [@bib34]), but the downstream mechanism is unclear. Here, in this paper, we prove that severe injury activated *yap* directly binds *lin28a* promoter for transcriptional initiation. *Lin28a* acts downstream of *yap* to regulate progenitor regeneration.

The mechanism of *yap* activation post severe injury remains elusive. It is hypothesized that either injured cells secrete diffusible molecules leading to widespread *yap* activation, or the damage of cell junction adjacent to the injury site activates *yap* ([@bib34]). We observed *lin28a* induction after laser ablation of HCs in the restricted areas. Our results showed that the *lin28a*-expressing cells were very close to the damaged HCs ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}), suggesting that the damage of cell junction might lead to yap-lin28a activation. In addition, we have noticed that not only HC injury but also the ablation of SCs was able to induce *lin28a* ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}), indicating that the injury of either HCs or SCs triggers yap-lin28a activation. Since cell-junction-associated protein *amotl2a* has been reported restricting *yap* activity in the zebrafish lateral line primordium ([@bib2]), it is possible that the loss of *amotl2a* post HC injury might result in *yap* activation. This assumption requires further investigation.

The cellular mechanism mediated by Yap-lin28a pathway that regulates progenitor regeneration {#s3-3}
--------------------------------------------------------------------------------------------

It was reported that lin28b-let7 functions to enhance progenitor proliferation during embryonic inner ear development ([@bib14]), but the downstream pathway is still unknown. Our data showed that lin28a-let7 functions to promote progenitor proliferation during regeneration, which is consistent with the previous finding that *lin28a* regulates retinal regeneration through *let7* ([@bib38]). Our results indicate that Wnt pathway acts downstream of lin28a-let7 for promoting progenitor regeneration. Hippo and Wnt pathway genes, such as *yap1*, *wnt10a*, *mycn*, *cyclind1*, were highly induced by Yap-lin28a post severe injury. During early development the lateral line primordium that migrates from head to tail deposits neuromasts in the trunk. Hippo and Wnt pathway genes, which are highly expressed in the leading edge of the migrating primordium containing mostly the undifferentiated mesenchymal-like progenitors ([@bib3]; [@bib25]), get silenced when the leading progenitors differentiate into SCs and HCs ([@bib22]; [@bib25]). However, the severe-injury-treated neuromast displayed the expression patterns of leading progenitors in early developing primordium, which suggests that *lin28a* reprograms the differentiated cells into the stem/progenitor cells at early developmental stage.

Although resident stem/progenitor cells are required for homeostasis and regeneration in most tissues, emerging evidence implies that differentiated cells are able to reprogram to stem/progenitor cells upon tissue damage to initiate regeneration ([@bib27]; [@bib42]). For example, atoh1^+^ secretory cells in intestine are capable to dedifferentiate into lgr5^+^ stem cells in irradiation-induced severe injury ([@bib43]; [@bib44]). In colon, atoh1^+^ secretory progenitors reprogram to lgr5^+^ stem cells and form the entire crypts post injury while contributed minimally to other lineages in homeostasis ([@bib8]). Since it's well-known that lin28a, together with Oct4, Sox2 and Nanog, can reprogram somatic cells to induced pluripotent stem cells (iPSC) in mouse and human ([@bib56]; [@bib33]; [@bib57]), it may be involved in tissue regeneration through dedifferentiation. Our results showed that *atoh1a*^+^ HC precursors were converted into sox2 expressing cells through Yap-lin28a pathway ([Figure 5](#fig5){ref-type="fig"}), suggesting that *lin28a* may reprogram HC precursors into sox2^+^ progenitors. Further lineage-tracing analyses using cre/loxP system is necessary to verify whether HC precursors are dedifferentiated into sox2^+^ progenitors post severe injury.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                     Designation                                     Source or\                 Identifiers                                                                                     Additional\
  (species) or\                                                                     reference                                                                                                                  information
  resource                                                                                                                                                                                                     
  --------------------------------- ----------------------------------------------- -------------------------- ----------------------------------------------------------------------------------------------- ------------------------------------
  Genetic reagent (*Danio rerio*)   *Et(krt4:EGFP)^sqet20ET^*                       [@bib36]                   sqET20; RRID:[ZFIN_ZDB-ALT-070628-20](https://scicrunch.org/resolver/ZFIN_ZDB-ALT-070628-20)    

  Genetic reagent (*Danio rerio*)   *Et(krt4:EGFP)^sqet4ET^*                        [@bib36]                   sgET4; RRID:[ZFIN_ZDB-GENO-110323-1](https://scicrunch.org/resolver/ZFIN_ZDB-GENO-110323-1)     

  Genetic reagent (*Danio rerio*)   *Tg(atoh1a:*\                                   [@bib47]                   nns8; RRID:[ZFIN_ZDB-GENO-120530-1](https://scicrunch.org/resolver/ZFIN_ZDB-GENO-120530-1)      
                                    *TdTomato)^nns8^*                                                                                                                                                          

  Genetic reagent (*Danio rerio*)   *sox2-2a-sfGFP^stl84^*                          [@bib40]                   stl84; RRID:[ZFIN_ZDB-GENO-150721-11](https://scicrunch.org/resolver/ZFIN_ZDB-GENO-150721-11)   

  Genetic reagent (*Danio rerio*)   Tg(*brn3c:GAP43-GFP*) ^s356t^                   [@bib52]                   S356t; RRID:[ZFIN_ZDB-GENO-200218-3](https://scicrunch.org/resolver/ZFIN_ZDB-GENO-200218-3)     

  Genetic reagent (*Danio rerio*)   *Tg(hsp70l:dkk1-GFP)^w32^*                      [@bib41]                   W32; RRID:[ZFIN_ZDB-ALT-070403-1](https://scicrunch.org/resolver/ZFIN_ZDB-ALT-070403-1)         

  Genetic reagent (*Danio rerio*)   *Tg(hsp70l:myc-notch1a;cryaa:Cerulean)^fb12^*   [@bib59]                   fb12; RRID:[ZFIN_ZDB-ALT-140522-5](https://scicrunch.org/resolver/ZFIN_ZDB-ALT-140522-5)        

  Genetic reagent (*Danio rerio*)   *Tg(hsp70:atoh1a)^x20^*                         [@bib31]                   X20;\                                                                                           
                                                                                                               RRID:[ZFIN_ZDB-GENO-110315-10](https://scicrunch.org/resolver/ZFIN_ZDB-GENO-110315-10)          

  Genetic reagent (*Danio rerio*)   *yap^mw48^*                                     [@bib30]                   Ms48; RRID:[ZFIN_ZDB-ALT-160122-5](https://scicrunch.org/resolver/ZFIN_ZDB-ALT-160122-5)        

  Genetic reagent (*Danio rerio*)   *Tg(hsp70:lin28a-P2Amcherry;cmlc:GFP)^psi30^*   this paper                                                                                                                 Details in Fish strain information

  Genetic reagent (*Danio rerio*)   *Tg(hsp70:let7-P2AGFP;cryaa:Venus)*             this paper                                                                                                                 Details in Fish strain information

  Genetic reagent (*Danio rerio*)   *lin28a^psi37^*                                 this paper                                                                                                                 Details in Fish strain information

  Antibody                          anti-sox2 (Rabbit, polyclonal)                  Abcam                      Cat\# Ab97959; RRID:[AB_2341193](https://scicrunch.org/resolver/AB_2341193)                     IF(1:200)

  Antibody                          anti-yap (Rabbit, polyclonal)                   CST                        Cat\# 4912, RRID:[AB_2218911](https://scicrunch.org/resolver/AB_2218911)                        IF(1:200)

  Antibody                          anti-taz (Rabbit, polyclonal)                   Abcam                      Cat\# Ab84927; RRID:[AB_1925489](https://scicrunch.org/resolver/AB_1925489)                     IF (1:200), WB (1:500)

  Antibody                          anti-GFP (Mouse, monoclonal)                    Invitrogen                 Cat\# A11120; RRID:[AB_221568](https://scicrunch.org/resolver/AB_221568)                        IF(1:500)

  Antibody                          Anti-yap (Mouse, monoclonal)                    Santa Cruz                 Cat\# sc-271134; RRID:[AB_10612397](https://scicrunch.org/resolver/AB_10612397)                 WB (1:1000)

  Antibody                          Anti-lin28a (Rabbit, polyclonal)                CST                        Cat\# 3978; RRID:[AB_2297060](https://scicrunch.org/resolver/AB_2297060)                        WB (1:500)

  Antibody                          Anti-lats (Rabbit, monoclonal)                  CST                        Cat\# 3477; RRID:[AB_2133513](https://scicrunch.org/resolver/AB_2133513)                        WB (1:500)

  Antibody                          Anti-p-mob1\                                    CST                        Cat\# 8699; RRID:[AB_11139998](https://scicrunch.org/resolver/AB_11139998)                      WB (1:500)
                                    (Rabbit, monoclonal)                                                                                                                                                       

  Antibody                          Anti-β-actin (Mouse, monoclonal)                Sigma                      Cat\# A1978; RRID:[AB_476692](https://scicrunch.org/resolver/AB_476692)                         WB (1:2000)

  Antibody                          Anti-digoxingenin POD (sheep, polyclonal)       Roche                      11207733910; RRID:[AB_514500](https://scicrunch.org/resolver/AB_514500)                         1:2000

  Antibody                          Anti-fluorescein POD(sheep, polyclonal)         Roche                      11426346910; RRID:[AB_840257](https://scicrunch.org/resolver/AB_840257)                         1:2000

  Chemical compound, drug           EdU                                             Carbosynth                 NE08701                                                                                         3.3 mM

  Chemical compound, drug           LY411575                                        Santa Cruz                 sc-364529                                                                                       2 μM

  Chemical compound, drug           Neomycin sulfate                                Sigma                      N6386                                                                                           300 μM

  Chemical compound, drug           Alexa Fluor-594 Azide                           Thermo Fisher Scientific   N6386                                                                                           

  Chemical compound, drug           Verteporfin                                     Selleckchem                S1786                                                                                           5 μM

  Chemical compound, drug           Copper sulfate                                  Sigma                      451657                                                                                          50 μM

  Chemical compound, drug           cisplatin                                       Sigma                      33342                                                                                           500 μM

  Commercial assay or kit           TSA-Cyanine 3 Reagent                           PerkinElmer                SAT704A001EA                                                                                    

  ﻿Commercial assay or kit          TSA-FITC Reagent                                PerkinElmer                SAT704A001EA                                                                                    

  Commercial assay or kit           dynabeads                                       Invitrogen                 10015D                                                                                          
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fish strains {#s4-1}
------------

*Tg(sqET20;sgET4)* ([@bib36]), *Tg(atoh1a:TdTomato)^nns8^*([@bib47]), *sox2-2a-sfGFP^stl84^* ([@bib40]), Tg(*brn3c:GAP43-GFP*)^s356t^ or *brn3c:GFP*([@bib52]), *Tg(hsp70l:dkk1-GFP)^w32^* or *hs:dkk1* ([@bib41]), *Tg(hsp70l:myc-notch1a;cryaa:Cerulean)^fb12^* or *hs:notch1a* ([@bib59]), *Tg(hsp70:atoh1a)^x20^* or *hs:atoh1a* ([@bib31])*, yap^mw48^* ([@bib30]) were used. To generate *Tg(hsp70:lin28a-P2Amcherry;cmlc:GFP)^psi30^* or *hs:lin28a* line, the *lin28a* coding sequence was cloned into the Gateway destination vector containing the *hsp70* promoter. To generate *Tg(hsp70:let7-P2AGFP;cryaa:Venus)* or *hs:let7* line, the expression cassette of pri-*let-7a and pri-let-7f* in UI4-GFP-SIBR backbone ([@bib38]) was subcloned into the Gateway destination vector containing the *hsp70* promoter. To create *lin28a^psi37^* mutant or lin28a-/-, 50 pg Cas9 protein (PNA Bio) and 50 pg sgRNA (GAGGGTTTTCGCAGTCTGA) were injected per embryo. F0 founders were screened by genotyping F1 embryos with PCR (F: TGTTTGACATCTCTGCAGAGC, R:CACCGATCTCCTTTTGACCG) followed by Hpy188I digestion. The yap*^mw69^* mutant was genotyped with PCR primers (F:AGTCATGGATCCGAACCAGCACAA, R:TGCAATCGGCCTTTATTTTCCTGC) followed by HinfI digestion.

Pharmacological inhibitors and heat-shock experiments {#s4-2}
-----------------------------------------------------

The γ-secretase inhibitor LY411575 (Santa Cruz sc-364529) was added to larvae at 2 μM from 3dpf to 5dpf. The inhibitor of yap-tead1 complext verteporfin (Selleckchem S1786)was added to larvae at 5 μM. Larvae at 5dpf were heat-shocked at 39°C for 30 min and sometimes heat-shock is repeated to maintain the target gene expression. *hs:lin28a* or *hs:let7* larvae were sorted by GFP in heart or Venus in eye at 3dpf. *hs:notch1a* were sorted by Cerulean fluorescence in eye at 3dpf. And *hs:dkk1* larvae were sorted by GFP after heat-shock. *hs:atoh1a* were genotyped by primers GCAGCCTGACAGGACTTTTC and GCTGCTCTTCCTGAAGTTGG.

### Regeneration experiments, EdU incorporation {#s4-2-1}

To ablate HCs, larvae at 5dpf were treated with 300 μM neomycin (Fisher Scientific) for 30 min, 500 μM cisplatin (Sigma Aldrich, 33342) for 2 hr, or 50 μM CuSO4 (Sigma Aldrich, 451657) for 2 hr. To ablate both SCs and HCs to induce severe injury, we added 2 μM LY411575 from 3dpf to 5dpf and then treated with neomycin. Afterwards, larvae were first rinsed three times in fresh 0.5x E2 medium, and incubated in fresh medium. EdU (Carbosynth, NE08701, diluted in 3.3 mM with E2 medium containing 1% DMSO) was used to label larvae for the indicated time at 28.5°C before collecting for staining. Incorporated EdU was stained with Azide-594 (Invitrogen, N6386). The numbers and relative positions of EdU-positive cells in neuromast were analyzed as described in [@bib39].

### In situ hybridization {#s4-2-2}

The following probes were used: *atoh1a*, *her4.1*, *fgf3*, *wnt10a* ([@bib22]), *yap1*, *mst2*([@bib25]), *mycn*, *ccnd1*([@bib53]), *s100t*([@bib45]), *dkk2* ([@bib48]). *lin28a* was cloned with primers (F: CATTACCATCCCGTGAAGAGGGTCCTGGTTCTG and R: CCAATTCTACCCGTGTGCAACAACACACTCAGC) and subcloned into pPR-T4P for probe synthesis. In situ hybridization was performed as described in [@bib22]. Digoxigenin-labeled *atoh1a* probe and fluorescein-labeled *lin28a* probe were used for double fluorescent in situ. We first incubated the larvae with *atoh1a* probe followed by anti-digoxingenin POD antibody and colorized with TSA-FITC substrate. Then samples were incubated with *lin28a* probe followed by anti-fluorescein POD antibody and colorized with TSA-Cyanine 3 substrate.

### Immunostaining and live imaging {#s4-2-3}

Antibodies against sox2 (Abcam, Ab97959), yap (Cell Signaling Technology, 4912), taz (Abcam, Ab84927), GFP (Invitrogen, A11120) were used for immunostaining as described in [@bib25]. Images were acquired on a Zeiss LSM780 or LSM800 confocal microscope using an Apochromat 40 × 1.1 NA objective. For time-lapse imaging larvae at 5dpf were anesthetized with tricaine and mounted in 1.2% low melting point agarose on glass bottom dishes.

### Western blot and CHIP experiments {#s4-2-4}

About 30 larvae at 5dpf were lysed with 150 μl SDS buffer (63 mM Tris-HCl PH6.8, 10% glycerol, 100 mM DTT, 3.5% SDS) to extract protein for western blot. The primary antibodies used are yap (Santa Cruz, sc-271134), lin28a (CST, 3978), taz (Abcam, Ab84927), lats1 (CST, 3477), p-mob1 (CST 8699), β-actin (Sigma, A1978). CHIP experiments were performed as described in zfin (<https://wiki.zfin.org/display/prot/Chromatin+Immunoprecipitation+%28ChIP%29+Protocol+using+Dynabeads>). Antibody against yap (Santa Cruz, sc-271134) and dynabeads (Invitrogen, 10015D) were used to immunoprecipitate yap-bound nuclear DNA. PCR was performed with primers F:GATAATGATTGCATCACGTGAC and R:CATGCAGGATTCTTGGATGC to detect the region surrounding transcription start site of *lin28a*.

### Laser ablation {#s4-2-5}

Larvae at 5dpf were mounted in agarose and numbered individually for laser ablation. Laser ablation was performed with a Chameleon Ultra II laser tuned to 800 nm. Regions of 2 μm diameter were bleached for 30 cycles in ZEN. Illumination power was adjusted as necessary to ensure that destruction of the targeted regions occurred but limited to only targeted areas. This could range anywhere from 40 mW to 400 mW and varied from sample to sample. Imaging was performed with an LD C-Apochromat 40 × 1.1 NA objective, with 0.5 μm pixel spacing and 1.6μs dwell time with 512 × 512 pixels. The numbered larvae were then recovered and fixed in 4% PFA for testing in situ individually.

### Yap expression analysis {#s4-2-6}

Individual nuclei, labeled with DAPI, were automatically identified by finding local maxima on a Lorentzian of Gaussian filtered image. The area around identified points was automatically quantified in the yap channel. A yap-positive and yap-negative cell were manually selected from the vicinity of each neuromast, and only cells having intensity above the positive were counted as yap-nuclear-positive. All processings were done in ImageJ, and customized macros and plugins can be found at <https://github.com/jouyun/smc-macros/blob/master/2DSpotFinder.ijm>.

### Cell counting and data analysis {#s4-2-7}

GFP in *ET20* was used to label MC while GFP in *ET4* was used to label HC. The SC number was counted by DAPI stained cells with no *ET4;ET20* expression. About 3--4 neuromasts from 4 to 6 fish were used for cell counting. The polarization analysis was performed as in [@bib39], and the enrichment in dorsal-ventral poles was calculated by Binomial analysis. All data are presented as the mean ± s.e.m. Statistical analyses were performed using Student's t-test for experiments with two groups. One-way ANOVA was used for more than two groups. \* indicates p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001.
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**Acceptance summary:**

This paper examines regeneration following hair cell damage in the developing zebrafish lateral line, a tractable model system for hearing loss. The authors use genetic and pharmacological approaches to demonstrate a role for a key signalling pathway in the recovery of lateral line hair cells following chemically-induced injury.

**Decision letter after peer review:**

\[Editors' note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.\]

Thank you for submitting your work entitled \"Yap-lin28a axis reprograms committed hair cells to progenitors for initiating regeneration\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Shawn Burgess (Reviewer \#3).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

The manuscript tackles the interesting topic of hair cell regeneration in the lateral line of the zebrafish, using an injury model to examine the role of a yap-lin28a pathway in regenerating cells. The reviewers have pointed out several strengths of the study, but also raise a number of concerns. It was felt that there would be significant additional work necessary to meet these concerns, and that some of the conclusions were overstated. The reviewers have a number of specific suggestions, and we hope these will be useful to you in moving the work forward. The full reviews are appended below.

Reviewer \#1:

This study uses a novel injury model to deplete both hair cells and surrounding supporting cells in the larval zebrafish lateral line, allowing the researchers to more closely mimic the mature mammalian inner ear, which does not contain viable progenitor cells. The experiments overall are sound, and the team makes elegant use of several heat shock lines to temporally regulate gene expression during damage and regeneration. The primary findings are that the lateral line is capable of regeneration after a severe injury, and that this regeneration is dependent on the yap-lin28-let7-Wnt pathway, while this pathway is not required for regeneration if supporting cells are still intact. This finding is novel and exciting, as the authors have identified a pathway that is necessary for regeneration in the absence of progenitor cells.

1\) The findings are clearly supported by the data, although I have a reservation about the conclusion that \"yap directly binds *lin28a* promoter for transcriptional initiation.\" The authors convincingly show that yap can bind the *lin28a* promoter, and that *lin28a* is sufficient to induce regeneration, but not that yap binding of the *lin28a* promoter is necessary for the regenerative response.

2\) My other concern is the conclusion that sox2^+^/*atoh1a*^+^ cells present after LY+neo treatment truly represent dedifferentiated cells. The images in Figure 5E show that a brn3c^-^ cell expressing the *atoh1a* reporter dTomato can divide to produce two hair cells, even without a severe injury. These data suggest that *atoh1a* can label a subset of progenitor cells in the lateral line, even if these cells are sox2^-^. I agree that their LY+neo injury model increases the number of sox2^+^/*atoh1a*^+^ cells, but I am not fully convinced that these cells are dedifferentiated hair cells; they may be an intermediate progenitor cell or hair cell precursor. Similarly, I am not convinced that the cells expressing weak tubulin label in Figure 6 are dedifferentiated cells; these could be newly born hair cells, since EdU is retained following cell division. I do not think additional experiments are necessary, but rather suggest toning down the conclusions.

Reviewer \#2:

This manuscript reports work done in zebrafish aimed at further clarifying the mechanism underlying hair-cell regeneration.

The authors report that *atoh1a*^+^ committed hair cells de-differentiate into sox2^+^ progenitors upon injury, which initiates regeneration through a yap-lin28a-let7-Wnt pathway. They claim that their findings \"shed light on restoration of progenitors by dedifferentiation to initiate HC regeneration in mammals.\"

I do not share their persuasion, however.

Their data does not demonstrate hair-cell de-differentiation because *atoh1a*^+^ cells can be hair-cell progenitors that are constantly normally produced in neuromasts, or cells whose *atoh1a* expression is transitory and may not stabilise to eventually become progenitors or hair cells.

Therefore, I cannot support the publication of this work.

The authors claim that in a developing neuromast, *atoh1a* marks committed sensory hair cells. Yet, there is published data showing that this is not the case, as some non-sensory supporting cells express *atoh1a*.

Their sentence \"powerful capacity to regenerate HCs sustains after multiple rounds of damage...\" references Cruz et al., 2015. This in one of two concurrent papers showing regeneration after multiple rounds of hair-cell ablation. The second is Pinto-Teixeira et al., 2015, which should be cited as well.

They state that the above papers \"indicates that a population of stem/progenitor cell pool exists to self-renew and regenerate.\" However, there is ample evidence that the entire supporting cell population is able to convert to a stem cell-like is necessary. In other words, a stem cell population as a persistent cellular state has not been demonstrated.

\"Sox2 marks the proliferative progenitors that produce both SCs and HCs in homeostatic and regenerative NMs (21).\"

This is true, but only because sox2 is expressed by nearly every non-sensory cell. Because sensory cells are postmitotic, their conclusion is obvious.

\"These results indicate that sox2^+^ progenitors in neuromast have high potential to restore themselves when exhausted by severe injury.\"

Again, true and obvious because sox2 is expressed by nearly every non-sensory cell.

\"These results indicate that intensive proliferation is necessary to facilitate regeneration post severe injury.\"

This has been shown by no less than 10 previous papers already.

Nuclear localized yap was inhibited when *atoh1a* is inhibited with *hs:notch1a*, which suggests that yap is activated in *atoh1a*^+^ committed HCs.

This is puzzling because hair cells are postmitotic. In addition, is nuclear localization of yap takes place in *atoh1a*^+^ cells and activated Notch blocks the production of these cells, it is only obvious that the authors will see no nuclear localized yap.

\"Taken together, we found that yap is highly activated by severe injury and binds directly to *lin28a* promoter to initiate its transcription in *atoh1a*^+^ committed HCs.\"

I could not find direct evidence that yap binds *lin28a* promoter. It would help me if the authors pointing the data supporting the claim.

\"We found that the regenerated HC number was decreased by *lin28a* deficiency (Figure 3A).\"

What I see is that the entire neuromast was nearly half the size. Reduced hair-cell numbers may be an indirect consequence of lower proliferation, cellular extrusion or increased cell death.

\"The proliferative SCs are localized in dorsal and ventral poles of neuromast in homeostasis and neo-induced regeneration\"

They reference Romero-Carvajal et al., 2015. Yet, earlier reports of the patterns of supporting-cell proliferation are: Ma et al., 2008, and Wibowo et al., 2011.

\"The *atoh1a*:*dTomato* reporter labeled a part of but not all *ET4* positive mature HCs in normal condition, indicating that the reporter is very mosaic (Figure 5C, ctrl).\"

An alternative interpretation, supported by findings of Wibowo et al., 2011, is that *atoh1a*:*dTomato* is expressed by supporting cells that may not advance to the hair-cell progenitor or hair-cell fates.

\"However, more than half of the dTomato^+^ cells turned on sox2 expression at 12h and 48h post LY+neo and become dTomato^+^sox2^+^ cells (Figure 5D), suggesting that *atoh1a*^+^ cells were converted to sox2^+^ progenitors upon severe injury.\"

Again, because sox2 is expressed by nearly every non-sensory cell, it is not surprising that some cells will co-express *atoh1a* and sox2.

\"However, it\'s only in LY+neo-induced severe injury that dTomato^+^ cells converted to sox2^+^ cells labeled by *sox2:GFP* (white dots in Figure 5F and Video 3), which confirms the dedifferentiation of *atoh1a*^+^ cells into sox2^+^ progenitors."

This statement is not supported by evidence presented in the manuscript.

Reviewer \#3:

Ye et al. have submitted a manuscript that describes the interplay between the expression of sox2, lin28a, and *atoh1a* in the context of a zebrafish regenerating lateral line neuromast. The authors show that under normal conditions, *lin28a* plays at best a minor role in regeneration, it is induced in a small number of cells but a genetic knockout of *lin28a* does not have a measurable effect on lateral line hair cell regeneration after ablation with neomycin. In contrast, when notch signaling is inhibited, lateral inhibition from hair cells is blocked and you see supernumerary hair cells at the expense of supporting cells, which are the normal source of new hair cells after ablation. Under these conditions, the authors show atoh1 positive cells will induce *lin28a* and revert to a more support cell-like identity. This phenomenon is mediated via yap signaling and downstream of *lin28a* let7 is blocked, triggering Wnt signaling. When the support cells are depleted by notch inhibition, now a *lin28a* KO has a significant negative effect on hair cell regeneration. In general this is a very carefully done set of experiments that identifies an interesting gene pathway that would be difficult to recognize under typical conditions used to study regeneration. I have one significant additional experiment I would like to see.

1\) The hypothesis and the evidence point to *lin28a* triggering down-regulation of *atoh1a* and a return to a support cell fate. It should therefore be true that in the earlier developing larvae, if you induced *lin28a* expression ectopically, you should be able to inhibit natural differentiation of hair cells. Part of the model presented is that *lin28a* dedifferentiated cells contribute to new supporting cell populations too. Is it possible that the *lin28a* cells can only go \"backwards\" far enough to divide but not far enough to become support cells again? Under those circumstances the new support cells could come from the mantle cells which have been shown to be capable of fully regenerating all cell types in the neuromast. If it is really complete dedifferentiation, there should be more supporting cells in these larvae and not cells that are neither HC nor SC. It would be interesting if there could be lineage tracing of \"dedifferentiated\" atoh1^+^ cells. Can they actually become supporting cells?

\[Editors' note: further revisions were suggested prior to acceptance, as described below.\]

Thank you for submitting your article \"Yap-lin28a axis targets let7-Wnt pathway to restore progenitors for initiating regeneration\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Kathryn Cheah as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Shawn Burgess (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. Please aim to submit the revised version within two months, but we are happy to extend this timeframe if needed, given the current situation which may restrict experimental work time.

Summary:

In the present study, Zhian Ye and colleagues took advantage of the zebrafish lateral line to further dissect the mechanisms enabling the mechanosensory organs of some vertebrates to regenerated while other, including the mammalian inner ear cannot. The zebrafish lateral line presents two major advantages for this study: (i) the mechanosensory organs can almost entirely regenerate and (ii) severe damages can be perform suing chemical inhibitor treatments. Here the authors show that:

1\) Sox2 positive progenitors can largely regenerate after being fully illuminated in so-called severe injury after a combination of treatment with a Notch inhibitor (to promote the differentiation of support cells into hair cells) and an antibiotic (to damage the hair cells).

2\) The regenerating sox2-positive cells derive from *atoh1a*-positive, committed hair cells.

3\) The Hippo signaling pathway effector yap is upregulated upon severe injury, is required for regeneration of sox2-positive cells and induces the expression of lin28a.

4\) *Lin28a* is necessary and sufficient to induce the regeneration of sox2-positive progenitors.

5\) Progenitor regeneration results from a yap1-Lin28a-Let7-sox2-Wnt axis.

Essential revisions:

1\) Improve the Western blots to strengthen the data here. At the moment, the immunostainings are not clear, and the increase in yap1 is not clear on the Western blot. Indicate Molecular Weight on the blot.

2\) Confirm the specificity of your antibodies by checking on yap1 mutants.

3\) Confirm the specificity of the verteporfin inhibitor by comparing to the phenotype of yap1 mutants.

4\) Please attend to all the listed minor revisions and, where possible, to any other major revisions, such as citation of additional studies in the Introduction (or provide a rebuttal of these points).

The full reviews are appended below for your information, in particular, please refer to the detailed comments from reviewer 2.

Reviewer \#2:

The study reveals an interesting, new mechanism driving neuromast regeneration upon severe injury. While I think the study is potentially interesting for *eLife* readership, I feel some parts are not as solid as others, in particular the part on the role of yap1. Please see my specific comments below.

1\) The Introduction is short and miss to refer to some important studies that have been published on similar questions including, for example, work from the Lopez-Shier lab (PintoTeixeira et al., 2015, ViaderLlargues et al., 2018, for example)

2\) Using *hs:notch1a* to block *Atoh1a* function is not ideal. The authors should use *atoh1a* mutants which are available or Morpholino which have been published.

3\) The authors should demonstrate the specificity of the *yap1* and taz antibodies they are using by showing the absence of signal in respective mutants (available). These controls should be shown both for western-blot and immunostaining.

4\) On the western-blot in Figure 2---figure supplement 2B, taz seems to be much more upregulated than yap1. Why do the authors then focus exclusively on yap1?

5\) The yap signal and the difference between control and treated in Figure 4C and 4E are not convincing.

6\) \"The induction of yap and mst2 was blocked by verteporfin, an inhibitor of yap-mediated transcription by blocking yap-tead1 interaction\": why are the expression of yap and mst2 blocked upon inhibition of yap-mediated transcription? Has it previously been shown that yap and mst2 are transcriptional targets of yap? The authors should look at classical yap/taz transcriptional targets.

7\) Several yap and taz zebrafish mutants have been published. The authors should perform experiments in these mutants instead of -- or in addition to -- verteporfin experiments.

8\) \"We used CHIP-PCR to verify that yap binds to a region 100bp downstream of *lin28a* transcription start site\". How did the author choose this region?

9\) Figure 3A: does the Y-axis indicate EdU cell number (as indicated on the figure) or absolute numbers of HS, SC and MC (as the text suggests)?

10\) \"The EdU positive SC cells that were located in each quadrant with no polarization in sibling post LY+neo were almost cleared in *lin28a* mutant (Figure 3C-D)\": The link to polarization all the sudden here is not clear.

11\) Figure 3F: the authors should use yap mutants in addition to Verteporfin treatment.

10.7554/eLife.55771.sa2

Author response

\[Editors' note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors' response to the first round of review.\]

> The manuscript tackles the interesting topic of hair cell regeneration in the lateral line of the zebrafish, using an injury model to examine the role of a yap-lin28a pathway in regenerating cells. The reviewers have pointed out several strengths of the study, but also raise a number of concerns. It was felt that there would be significant additional work necessary to meet these concerns, and that some of the conclusions were overstated. The reviewers have a number of specific suggestions, and we hope these will be useful to you in moving the work forward. The full reviews are appended below.

In response to the reviewers, we have added several important references, copyedited the text, toned down some of our conclusions. Based on suggestions of reviewer 1, I toned down our conclusions about dedifferentiation. I changed the title to "Yap-lin28a axis targets let7-Wnt pathway to restore progenitors for initiating regeneration". Instead of drawing the conclusion that *atoh1a*^+^ HC precursors were dedifferentiated, we now changed it to that *atoh1a*^+^ HC precursors gained sox2 expression post severe injury. I have deleted all the data with acetylated tubulin (original Figure 6D-G) since a reference (Liu et al., 2018) I have just read showed that it labels not only HCs but also SCs. Therefore, it's not appropriate to use acetylated-tubulin as a specific marker for HC to test the fate change. Based on suggestions of reviewer 3 I have changed the nomination of *atoh1a*^+^ cells from committed HCs into HC precursors since *atoh1a* expression is shut down in mature HCs.

To answer the reviewer's questions, we have made new experiments and integrated the results to the updated figures.

1\) As pointed by all reviewers, we have used *atoh1a:dTomato* reporter to trace dTomato expression in HCs, SCs and MCs in normal condition, post normal and severe injury. Our new data in updated Figure 5---figure supplement 1C-D showed that *atoh1a* label mostly HCs and a small number of SCs in normal and neo-treated larvae. Higher number of *atoh1a*^+^ SCs was detected in LY+neo compared with neo. More importantly, many MCs were also labeled with *atoh1a* post LY+neo, which was not detected in normal or neo. This piece of data suggests that *atoh1a*^+^ cells behaved like progenitor/stem cells that give rise to many support cell types post severe injury.

2\) As suggested by reviewer 3, we have tested *hs:lin28a* for HC differentiation during development. Our results showed that *lin28a* expression has no effect on developing HC.

I believe that the quality of the revised version is highly improved thanks to the reviewers' comments.

> Reviewer \#1:
>
> \[...\]
>
> 1\) The findings are clearly supported by the data, although I have a reservation about the conclusion that \"yap directly binds lin28a promoter for transcriptional initiation.\" The authors convincingly show that yap can bind the lin28a promoter, and that lin28a is sufficient to induce regeneration, but not that yap binding of the lin28a promoter is necessary for the regenerative response.

Verteporfin is a specific inhibitor that blocks the transcriptional activity of yap by inhibiting yap and tead interaction. Our data in Figure 3F showed that verteporfin inhibited regenerative proliferation which mimicked the phenotype of *lin28a* mutant. This piece of data indicated that yap binding of the *lin28a* promoter is necessary for the regenerative response. We have also tested yap mutants for regeneration post severe injury. Unfortunately, they all died after adding EdU post LY+neo, possibly because of their weakness caused by vascular and heart defect.

> 2\) My other concern is the conclusion that sox2^+^/atoh1a^+^ cells present after LY+neo treatment truly represent dedifferentiated cells. The images in Figure 5E show that a brn3c^-^ cell expressing the atoh1a reporter dTomato can divide to produce two hair cells, even without a severe injury.

It's known that the lateral line HCs are born in pairs from the terminal mitotic division of *atoh1a*^+^ HC precursors in development and post neo (Pinto-Teixeira et al., 2015). Based on reviewer 3's suggestion, we have changed the nomination of *atoh1a*^+^ cells from committed HCs to HC precursors since mature HCs lose *atoh1a* RNA expression. Our data (blue dots in updated Figure 4---figure supplement 1A-B) are consistent with this conclusion by showing that one *atoh1a*^+^ precursor divided and became two brn3c^+^ HCs post neo.

> These data suggest that atoh1a can label a subset of progenitor cells in the lateral line, even if these cells are sox2^-^. I agree that their LY+neo injury model increases the number of sox2^+^/atoh1a^+^ cells, but I am not fully convinced that these cells are dedifferentiated hair cells; they may be an intermediate progenitor cell or hair cell precursor.

Thank you to the reviewer for suggesting toning down the conclusions. Our new data in updated Figure 5---figure supplement 1C-D showed that *atoh1a* label mostly HCs and a small number of SCs in normal and neo-treated larvae. Higher number of *atoh1a*^+^ SCs was detected in LY+neo compared with neo. More importantly, many MCs were also labeled with *atoh1a* post LY+neo, which was not detected in normal or neo-treated conditions. This piece of data suggests that *atoh1a*^+^ cells behaved like progenitor/stem cells that give rise to many support cell types post severe injury. However, the lineage tracing experiment using cre/loxP system is necessary to confirm whether *atoh1a*^+^ cells are dedifferentiated or not.

Since we were not able to do this experiment because of technology reason, we have already toned down the conclusions in our manuscript. Now the dedifferentiation conclusion was changed to that *atoh1a*^+^ HC precursors gained sox2 expression post severe injury.

> Similarly, I am not convinced that the cells expressing weak tubulin label in Figure 6 are dedifferentiated cells; these could be newly born hair cells, since EdU is retained following cell division. I do not think additional experiments are necessary, but rather suggest toning down the conclusions.

We have decided to delete all the data with acetylated tubulin since it's not a specific marker for HC. A reference I have just read described that not only HCs but also SCs have acetylated tubulin expression in mouse inner ear (Liu et al., 2018, Eur J Histochem). Therefore, it's not appropriate to use acetylated tubulin as a specific HC marker to test whether HCs were co-labeled with sox2 and EdU.

> Reviewer \#2:
>
> This manuscript reports work done in zebrafish aimed at further clarifying the mechanism underlying hair-cell regeneration.
>
> The authors report that atoh1a^+^ committed hair cells de-differentiate into sox2^+^ progenitors upon injury, which initiates regeneration through a yap-lin28a-let7-Wnt pathway. They claim that their findings \"shed light on restoration of progenitors by dedifferentiation to initiate HC regeneration in mammals.\"
>
> I do not share their persuasion, however.
>
> Their data does not demonstrate hair-cell de-differentiation because atoh1a^+^ cells can be hair-cell progenitors that are constantly normally produced in neuromasts, or cells whose atoh1a expression is transitory and may not stabilise to eventually become progenitors or hair cells.
>
> Therefore, I cannot support the publication of this work.
>
> The authors claim that in a developing neuromast, atoh1a marks committed sensory hair cells. Yet, there is published data showing that this is not the case, as some non-sensory supporting cells express atoh1a.

I agree with the reviewer that non-sensory SCs express *atoh1a* to become HC precursors. Based on *atoh1a* in situ results (Figure 2C) 6.42%±0.68% SCs express *atoh1a* in 5dpf larvae. Based on our new analysis with *atoh1a:dTomato* reporter in Figure 5---figure supplement 1D, 2.44%±1.03% SCs have dTomato expression in normal condition. However, data in Figure 5---figure supplement 1C-D showed that the ratio of dTomato^+^ SCs significantly increased to 41.78%± 8.47% in LY+neo. In addition, many MCs (49.05%±11.32%), which never express dTomato in 5dpf larvae and neo, were labeled by dTomato in LY+neo. These data suggest that *atoh1a*^+^ cells were converted into multipotential progenitors in severe injury.

However, the lineage tracing experiment using cre/loxP system is necessary to confirm whether *atoh1a*^+^ cells are dedifferentiated or not. Since we were not able to do this experiment because of technology reason, we have already toned down our conclusions about dedifferentiation in our manuscript.

> Their sentence \"powerful capacity to regenerate HCs sustains after multiple rounds of damage...\" references Cruz et al., 2015. This in one of two concurrent papers showing regeneration after multiple rounds of hair-cell ablation. The second is Pinto-Teixeira et al., 2015, which should be cited as well.

Thank the reviewer for the advice. We have added the other reference in the manuscript.

> They state that the above papers \"indicates that a population of stem/progenitor cell pool exists to self-renew and regenerate.\" However, there is ample evidence that the entire supporting cell population is able to convert to a stem cell-like is necessary. In other words, a stem cell population as a persistent cellular state has not been demonstrated.

The reviewer is correct that SCs are able to convert to a stem cell-like population in regeneration. Our results also indicate that *atoh1a*^+^ HC precursors gained sox2 expression to promote regeneration post severe injury. We have deleted the sentence in the text to avoid the confusion.

> \"Sox2 marks the proliferative progenitors that produce both SCs and HCs in homeostatic and regenerative NMs (21).\"
>
> This is true, but only because sox2 is expressed by nearly every non-sensory cell. Because sensory cells are postmitotic, their conclusion is obvious.

The reviewer is correct that most SCs have sox2 expression in normal injury. Counting results ([Author response image 1](#sa2fig1){ref-type="fig"}) show that about 60% of SCs or MCs are sox2^+^ in 5dpf normal and neo-treated larvae.

![Some SCs and MCs in neuromast are negative with sox2 expression.\
(**A**)*ET4;ET20* Larvae were treated with neo and immediately collected for sox2 immunostaining. The white arrowheads pointed out SCs and MCs that were sox2 negative. (**B**) Total number of SCs or MCs and sox2^+^ ones were counted, and sox2^+^ ratios were calculated. About 60% of SCs or MCs express sox2.](elife-55771-resp-fig1){#sa2fig1}

> \"These results indicate that sox2^+^ progenitors in neuromast have high potential to restore themselves when exhausted by severe injury.\"
>
> Again, true and obvious because sox2 is expressed by nearly every non-sensory cell.

I agree with the reviewer that most SCs have sox2 expression in normal injury. But the sox2 expression pattern has changed in our new severe-injury model. We found that very few sox2^+^ cells (2.83±0.61, LY+neo group, [Author response image 2A](#sa2fig2){ref-type="fig"}, also in original Figure 1B) survived. But many *atoh1a*^+^ cells (11.8±0.78, LY+neo group in [Author response image 2B](#sa2fig2){ref-type="fig"}, related with Figure 2C) were still alive and became the main population post severe injury (Figure 2C).

![Sox2^+^ progenitors were eliminated and *atoh1a^+^* HC precursors dominated post severe injury.\
(A) Larvae were treated with LY, neo or LY+neo and collected immediately after neo treatment for sox2 immunostaining. Sox2^+^ cell numbers were counted, and the results showed that very few sox2^+^ cells survived post LY+neo. (B) Larvae were treated with LY, neo or LY+neo and collected immediately after neo treatment for *atoh1a* RNA probe hybridization. Results showed that significantly higher number of *atoh1a*^+^ cells survived post LY+neo.](elife-55771-resp-fig2){#sa2fig2}

> \"These results indicate that intensive proliferation is necessary to facilitate regeneration post severe injury.\"
>
> This has been shown by no less than 10 previous papers already.

All the published papers used neo-treated model to analyze proliferation post normal injury. We compared LY+neo versus neo for EdU incorporation, and found that proliferation in SCs or MCs is highly increased (Figure 1---figure supplement 2). Therefore, we draw the conclusion that intensive proliferation facilitates regeneration post severe injury. Our finding is novel since this is the first study testing proliferation post severe injury.

> Nuclear localized yap was inhibited when atoh1a is inhibited with hs:notch1a, which suggests that yap is activated in atoh1a^+^ committed HCs.
>
> This is puzzling because hair cells are postmitotic. In addition, is nuclear localization of yap takes place in atoh1a^+^ cells and activated Notch blocks the production of these cells, it is only obvious thet the authors will see no nuclear localized yap.

We have collected LY+neo-treated *hs:notch1a* larvae to check yap immunostaining. Our data (Figure 2F) showed that *atoh1a*^+^ cells were eliminated in *hs:notch1a*. And data in updated Figure 2---figure supplement 2E showed that nuclear-localized yap was inhibited in *hs:notch1a*. Therefore, we concluded that yap is activated in *atoh1a*^+^ cells post LY+neo.

> \"Taken together, we found that yap is highly activated by severe injury and binds directly to lin28a promoter to initiate its transcription in atoh1a^+^ committed HCs.\"
>
> I could not find direct evidence that yap binds lin28a promoter. It would help me if the authors pointing the data supporting the claim.

In Figure 2H, we used yap-immunoprecipitated DNA extracts for PCR (CHIP-PCR) using primers against *lin28a* promoter. We added the location of PCR primers in the updated figure. Results showed that PCR product against *lin28a* promoter was detected post LY+neo but not in LY. This piece of data indicates that yap binds lin28a promoter post severe injury.

> \"We found that the regenerated HC number was decreased by lin28a deficiency (Figure 3A).\"
>
> What I see is that the entire neuromast was nearly half the size. Reduced hair-cell numbers may be an indirect consequence of lower proliferation, cellular extrusion or increased cell death.

Data in Figure 3A showed that HC number was decreased in *lin28a* mutant. The reviewer is correct that the HC decrease may be caused by loss of SC proliferation or other possible reasons. We didn't do further analysis since we mainly focus on progenitor proliferation rather than HC production in this manuscript. But thank the reviewer for pointing out other possibilities which we will further analyze in the future.

> \"The proliferative SCs are localized in dorsal and ventral poles of neuromast in homeostasis and neo-induced regeneration\"
>
> They reference Romero-Carvajal et al., 2015. Yet, earlier reports of the patterns of supporting-cell proliferation are: Ma et al., 2008, and Wibowo et al., 2011.

Thank the reviewer for the suggestion. We have added the other two references in the manuscript.

> \"The atoh1a:dTomato reporter labeled a part of but not all ET4 positive mature HCs in normal condition, indicating that the reporter is very mosaic (Figure 5C, ctrl).\"
>
> An alternative interpretation, supported by findings of Wibowo et al., 2011, is that atoh1a:dTomato is expressed by supporting cells that may not advance to the hair-cell progenitor or hair-cell fates.

Thank you to the reviewer for this comment. I learned from the published paper by Wibowo et al., 2011 that young HCs are dTomato^+^ cells and mature HCs lose dTomato expression. Therefore, the mosaic expression of dTomato in HCs in Figure 5C may be caused by different states of HC maturity. We have changed the description accordingly in the manuscript.

We found a few dTomato^+^ SCs in normal and neo conditions (Figure 5---figure supplement 1) and the number is highly increased post LY+neo.

> \"However, more than half of the dTomato^+^ cells turned on sox2 expression at 12h and 48h post LY+neo and become dTomato^+^sox2^+^ cells (Figure 5D), suggesting that atoh1a^+^ cells were converted to sox2^+^ progenitors upon severe injury.\"
>
> Again, because sox2 is expressed by nearly every non-sensory cell, it is not surprising that some cells will co-express atoh1a and sox2.

I agree with the reviewer that most SCs have sox2 expression in normal larvae. Atoh1 is expressed in differentiating HC precursors and our data showed that very few dTomato^+^sox2^+^ cells existed in normal neuromast (updated Figure 5A-D). In accordance, several publications showed that atoh1 and sox2 is antagonistic in development (Dabdoub et al., 2008, Zhang et al., 2017). But the number of dTomato^+^sox2^+^ cells was highly increased post LY+neo, indicating that *atoh1a*^+^ cells gained sox2 expression in severe injury.

> \"However, it\'s only in LY+neo-induced severe injury that dTomato^+^ cells converted to sox2^+^ cells labeled by sox2:GFP (white dots in Figure 5F and Video 3), which confirms the dedifferentiation of atoh1a^+^ cells into sox2^+^ progenitors. „
>
> This statement is not supported by evidence presented in the manuscript.

Our data in updated Figure 5---figure supplement 1B and Video 3 showed that the two blue-dotted dTomato^+^ cells were GFP negative in the beginning, and divided into four daughter cells which gained GFP expression. We have changed the conclusion about dedifferentiation to that *atoh1a*^+^ cells gained sox2 expression in severe injury. Thank the reviewer for pointing out this concern.

> Reviewer \#3:
>
> \[...\]
>
> 1\) The hypothesis and the evidence point to lin28a triggering down-regulation of atoh1a and a return to a support cell fate. It should therefore be true that in the earlier developing larvae, if you induced lin28a expression ectopically, you should be able to inhibit natural differentiation of hair cells.

Thank you to the reviewer for the suggestion. To address the question whether *lin28a* affect early differentiation, we have analyzed 3dpf and 5dpf *hs:lin28a* larvae for HC counting. The results (updated Figure 4---figure supplement 1) showed that *lin28a* has no effect on HC differentiation during development. Our data in Figure 3 and Figure 4 also indicate that *lin28a* has no effect on HC differentiation (HC+, EdU incorporated HCs). And data in updated Figure 6---figure supplement 1 showed that differentiation related gene *her4* was not changed in *hs:lin28a*. All these data indicate that lin28a has no effect on differentiation in either development or regeneration. It could be possible that new *atoh1a*^+^ HC precursors are produced when *lin28a* inhibits the differentiation of old *atoh1a*^+^ cells.

> Part of the model presented is that lin28a dedifferentiated cells contribute to new supporting cell populations too. Is it possible that the lin28a cells can only go \"backwards\" far enough to divide but not far enough to become support cells again? Under those circumstances the new support cells could come from the mantle cells which have been shown to be capable of fully regenerating all cell types in the neuromast. If it is really complete dedifferentiation, there should be more supporting cells in these larvae and not cells that are neither HC nor SC. It would be interesting if there could be lineage tracing of \"dedifferentiated\" atoh1^+^ cells. Can they actually become supporting cells?

Our new data in updated Figure 5---figure supplement 1C-D showed that *atoh1a* label mostly HCs and a small number of SCs in normal and neo-treated larvae. Higher number of *atoh1a*^+^ SCs was detected in LY+neo compared with neo. More importantly, many MCs were also labeled with *atoh1a* post LY+neo, which was not detected in normal or neo-treated conditions. This piece of data suggests that *atoh1a*^+^ cells behaved like progenitor/stem cells that give rise to many support cell types post severe injury. However, the lineage tracing experiment using cre/loxP system is necessary to confirm whether *atoh1a*^+^ cells are dedifferentiated or not. Since we were not able to do this experiment because of technology reason, we have already toned down the conclusions in our manuscript. Now the dedifferentiation conclusion was changed to that *atoh1a*^+^ HC precursors gained sox2 expression post severe injury.

\[Editors' note: what follows is the authors' response to the second round of review.\]

> Essential revisions:
>
> 1\) Improve the Western blots to strengthen the data here. At the moment, the immunostainings are not clear, and the increase in yap1 is not clear on the Western blot. Indicate Molecular Weight on the blot.
>
> 2\) Confirm the specificity of your antibodies by checking on yap1 mutants.
>
> 3\) Confirm the specificity of the Verteporfin inhibitor by comparing to the phenotype of yap1 mutants.
>
> 4\) Please attend to all the listed minor revisions and, where possible, to any other major revisions, such as citation of additional studies in the Introduction (or provide a rebuttal of these points).

Thank you for providing us the opportunity for revision. We also appreciate the time and effort of the two reviewers. Based on the reviewers' valuable comments we have performed a series of new experiments that were briefly summarized below.

1\) We have optimized the western-blot conditions to detect yap expression post severe injury. The new results clearly showed that yap is upregulated at 1h and 5h post LY+neo.

2\) We have used yap mutants to check the specificity of yap antibody by western-blot and immunostaining. The results showed that the yap antibody is very specific for detecting yap protein in siblings but not yap mutants.

3\) We have used yap mutants to confirm that yap is required for the severe-injury-induced regeneration.

4\) We also provided evidence that the classic target genes of yap such as cyr61 and ctgfa are upregulated post severe injury, which is inhibited by verteporfin.

> Reviewer \#2:
>
> The study reveals an interesting, new mechanism driving neuromast regeneration upon severe injury. While I think the study is potentially interesting for eLife readership, I feel some parts are not as solid as others, in particular the part on the role of yap1. Please see my specific comments below.
>
> 1\) The Introduction is short and miss to refer to some important studies that have been published on similar questions including, for example, work from the Lopez-Shier lab (PintoTeixeira et al., 2015, ViaderLlargues et al., 2018, for example)

Thanks to the reviewer for the nice suggestion. We have previously included PintoTeixeira et al., 2015 in the Introduction. Now we added ViaderLlargues et al., 2018 in the Introduction as an important reference for the high potential of SCs to regenerate after severe damage.

> 2\) Using hs:notch1a to block Atoh1a function is not ideal. The authors should use atoh1a mutants which are available or Morpholino which have been published.

In Figure 2F we found that LY+neo-induced *lin28a* is decreased in *hs:notch1a*. I agree with the reviewer that *atoh1a* mutants or *atoh1a* morpholino is more specific to block *atoh1a* function than *hs:notch1a*. However, HCs are absent in *atoh1a* mutants or morphants, which makes it impossible to cause severe damage by combined treatment of LY and neomycin. In order to induce severe damage, we have to use *hs:notch1a* to transiently block *atoh1a* expression without affecting hair cell development.

The aim of this experiment is to check whether *lin28a* is induced in *atoh1a* expressing cells. In addition to this piece of data, we observed that *lin28a* induction is increased in *hs:atoh1a* and *lin28a* is co-labeled with *atoh1a* post severe injury. All these evidences clearly indicate that *lin28a* is induced in *atoh1a*^+^ cells post severe injury.

> 3\) The authors should demonstrate the specificity of the yap1 and taz antibodies they are using by showing the absence of signal in respective mutants (available). These controls should be shown both for western-blot and immunostaining.

Our new results in updated Figure 2---figure supplement 2F showed that yap antibody had good immunostaining signal in LY+neo-treated neuromast, which was lack in yap mutants. Western-blot results in Figure 2---figure supplement 2C have detected the yap band in siblings but not in yap mutants. These results indicate that yap antibody is specific in recognizing yap protein.

> 4\) On the western-blot in Figure 2---figure supplement 1B, taz seems to be much more upregulated than yap1. Why do the authors then focus exclusively on yap1?

We have optimized the western-blot conditions with yap antibody and updated the Figure 2---figure supplement 2B results. We found that yap protein level was upregulated at 1h and 5h post LY+neo while taz was upregulated until 5h. In addition, yap but not taz was detected in neuromast by immunostaining at 1h post LY+neo (updated Figure 2---figure supplement 2D-G and data not shown). Based on these results, yap is activated earlier than taz post severe injury and might be responsible for regeneration. Indeed, we found that the regenerative proliferation and *lin28a* induction were blocked in yap mutants (Figure 3F and 2J). All these indicate that yap activation is required for severe-injury-induced regeneration.

> 5\) The yap signal and the difference between control and treated in Figure 4C and 4E are not convincing.

I assume the reviewer referred to Figure 2---figure supplement 2C and E in the original figures which were now updated as Figure 2---figure supplement 2D and Figure 2---figure supplement 2G. We have proved the specificity of yap antibody by using yap mutants in the updated Figures (details in major point 3). The signal of yap immunostaining seemed localized in both nucleus and cytoplasm of neuromast cells, possibly because yap shuttles between nuclei and cytoplasm. We also noticed that the injury induced yap expression not only in neuromast but also in surrounding skin and muscle. Only yap expressing cells within the neuromasts were chosen and divided by total cell number to calculate the ratio. The ratio of yap expression was significantly increased post LY+neo, which was inhibited in *hs:notch1a*.

> 6\) \"The induction of yap and mst2 was blocked by verteporfin, an inhibitor of yap-mediated transcription by blocking yap-tead1 interaction\": why are the expression of yap and mst2 blocked upon inhibition of yap-mediated transcription? Has it previously been shown that yap and mst2 are transcriptional targets of yap? The authors should look at classical yap/taz transcriptional targets.

Thanks to the reviewer for the suggestion. We have tested the classic yap transcriptional target genes cyr61 and ctgfa post severe injury by real time PCR. Results in updated Figure 2---figure supplement 2H indicated that expression levels of cyp61 and ctgfa were increased post severe injury, which was inhibited by verteporfin. This indicates that yap activity is activated post severe injury. Our results in updated Figure 2---figure supplement 2I suggested that yap probably upregulated expressions of itself and mst2 to create a positive feedback loop.

> 7\) Several yap and taz zebrafish mutants have been published. The authors should perform experiments in these mutants instead of -- or in addition to -- Verteporfin experiments.

Thanks to the reviewer for the suggestion. We have tested regenerative proliferation in yap mutants. The proliferation was significantly decreased in yap mutants (updated Figure 3F), which resembled the phenotype of verteporfin treatment (updated Figure 3G).

> 8\) \"We used CHIP-PCR to verify that yap binds to a region 100bp downstream of lin28a transcription start site\". How did the author choose this region?

We used the promoter region of *lin28a* to search for the conserved yap binding motif by sequence similarity. There is a yap binding motif located at 100bp downstream of *lin28a* transcription start site, where a tead1 binding motif is located nearby. This suggested that yap might cooperate with tead1 to activate *lin28a* transcription. We verified the binding of yap to this region by CHIP-PCR (Figure 2H).

> 9\) Figure 3A: does the Y-axis indicate EdU cell number (as indicated on the figure) or absolute numbers of HS, SC and MC (as the text suggests)?

Thanks to the reviewer for pointing out this typo. It should be the absolute number of HC, SC and MC, and we changed the Y-axis label accordingly.

> 10\) \"The EdU positive SC cells that were located in each quadrant with no polarization in sibling post LY+neo were almost cleared in lin28a mutant (Figure 3C-D)\": The link to polarization all the sudden here is not clear.

Results in Figure 3D showed that the EdU+ proliferative cells post LY+neo is not polarized since the statistical analysis is not significant (N.S. at the bottom). Therefore the severe-injury-induced proliferation is not polarized, which is unlike the dorsal-ventral localization of EdU+ cells post neo (Figure 4C and 4D).

> 11\) Figure 3F: the authors should use yap mutants in addition to Verteporfin treatment.

We have analyzed yap mutants for LY+neo-induced regeneration and added to updated Figure 3F. Please refer to point 7 for details.

[^1]: These authors contributed equally to this work.
